Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable, antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
